Skip to main content
Cyber Week Sale - Get 40% off Vantage
Published loading...Updated

A trial is underway that could be 'the last roll of the dice' for an HIV vaccine this decade

  • A novel trial called PrEPVacc is being conducted to test the efficacy of two HIV vaccines and two forms of pre-exposure prophylaxis in preventing the spread of HIV. The success of this trial could mark a new phase of vaccine development, while failure could lead to a setback for HIV vaccine research.
  • The medical community has been searching for an HIV vaccine for nearly 40 years, with only one clinical trial showing modest effectiveness in preventing infection. The PrEPVacc trial aims for an efficacy rate of at least 70% for the tested vaccines.
Insights by Ground AI

30 Articles

Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • 93% of the sources are Center
93% Center

Factuality Info Icon

To view factuality data please Upgrade to Premium

Ownership

Info Icon

To view ownership data please Upgrade to Vantage

CNN broke the news in Atlanta, United States on Monday, August 28, 2023.
Too Big Arrow Icon
Sources are mostly out of (0)

Similar News Topics

News
Feed Dots Icon
For You
Search Icon
Search
Blindspot LogoBlindspotLocal